Swiss Regulatory Aspects & Evaluation Considerations for mRNA Technology & Future Therapeutic Potential
Time: 9:15 am
day: Day Two AM
Details:
- Swissmedic Innovation Office – Visibility near the innovation, promote innovation
- Swissmedic’s Competence Center Advanced Therapy Medicinal Products (ATMP): ATMP Risk Based Approach
